211 related articles for article (PubMed ID: 11023519)
1. Treatment with liposome-encapsulated clodronate as a new strategic approach in the management of immune thrombocytopenic purpura in a mouse model.
Alves-Rosa F; Stanganelli C; Cabrera J; van Rooijen N; Palermo MS; Isturiz MA
Blood; 2000 Oct; 96(8):2834-40. PubMed ID: 11023519
[TBL] [Abstract][Full Text] [Related]
2. Rapid recovery of platelet count following administration of liposome-encapsulated clodronate in a mouse model of immune thrombocytopenia.
Alves-Rosa F; Stanganelli C; Cabrera J; Cymberknop D; Rubel C; Vanzulli S; van Rooijen N; Palermo M; Isturiz MA
Br J Haematol; 2002 Feb; 116(2):357-66. PubMed ID: 11841439
[TBL] [Abstract][Full Text] [Related]
3. Targeting study of gelatin adsorbed clodronate in reticuloendothelial system and its potential application in immune thrombocytopenic purpura of rat model.
Li P; Tan Z; Zhu Y; Chen S; Ding S; Zhuang H
J Control Release; 2006 Aug; 114(2):202-8. PubMed ID: 16857286
[TBL] [Abstract][Full Text] [Related]
4. Macrophage depletion following liposomal-encapsulated clodronate (LIP-CLOD) injection enhances megakaryocytopoietic and thrombopoietic activities in mice.
Alves-Rosa F; Vermeulen M; Cabrera J; Stanganelli C; Capozzo A; Narbaitz M; van Rooijen N; Palermo M; Isturiz MA
Br J Haematol; 2003 Apr; 121(1):130-8. PubMed ID: 12670343
[TBL] [Abstract][Full Text] [Related]
5. [Experimental study for thrombocytopenic purpura therapy by targeting macrophages in liver and spleen].
Tan ZH; Li PY; Zhu YH; Ji XW; Wu ZY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):103-7. PubMed ID: 17490532
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of corticosteroid action in immune thrombocytopenic purpura (ITP): experimental studies using ITP-prone mice, (NZW x BXSB) F1.
Mizutani H; Furubayashi T; Imai Y; Kashiwagi H; Honda S; Take H; Kurata Y; Yonezawa T; Tarui S; Ikehara S
Blood; 1992 Feb; 79(4):942-7. PubMed ID: 1737103
[TBL] [Abstract][Full Text] [Related]
7. [Initial 111In-platelet kinetics: indicator of platelet sequestration/destruction site or quality control of platelet labelling?].
Todorović-Tirnanić M; Obradović V; Rolović Z; Suvajdzić N; Elezović I; Colović M; Pavlović S; Starcević V; Bosnjaković V
Glas Srp Akad Nauka Med; 2005; (48):101-18. PubMed ID: 16405234
[TBL] [Abstract][Full Text] [Related]
8. Effects of splenectomy on immune thrombocytopenic purpura in (NZW x BXSB) F1 mice: analyses of platelet kinetics and anti-platelet antibody production.
Mizutani H; Furubayashi T; Kashiwagi H; Honda S; Take H; Kurata Y; Yonezawa T; Tarui S; Ikehara S
Thromb Haemost; 1992 May; 67(5):563-6. PubMed ID: 1519215
[TBL] [Abstract][Full Text] [Related]
9. Exacerbation of autoantibody-mediated thrombocytopenic purpura by infection with mouse viruses.
Musaji A; Cormont F; Thirion G; Cambiaso CL; Coutelier JP
Blood; 2004 Oct; 104(7):2102-6. PubMed ID: 15205264
[TBL] [Abstract][Full Text] [Related]
10. Functional studies of left upper quadrant mass aid management of idiopathic thrombocytopenic purpura.
Harwood SJ; Carroll RG
Clin Nucl Med; 1992 Aug; 17(8):652-5. PubMed ID: 1505130
[TBL] [Abstract][Full Text] [Related]
11. Prediction of the effect of immunoglobulin therapy in ITP.
Kawasugi K; Matsuda J; Abe T
Blut; 1989 Jul; 59(1):88-91. PubMed ID: 2752178
[TBL] [Abstract][Full Text] [Related]
12. [Prediction of the splenectomy efficacy in chronic immune thrombocytopenic purpura].
Todorović-Tirnanić M; Obradović V; Rolović Z; Suvajdzić N; Elezović I; Colović M; Pavlović S; Bosnjaković V
Glas Srp Akad Nauka Med; 2005; (48):119-35. PubMed ID: 16405235
[TBL] [Abstract][Full Text] [Related]
13. Clodronate-liposomes aggravate irradiation-induced myelosuppression by promoting myeloid differentiation.
Ju W; Lu W; Bao Y; Sun T; Adzraku SY; Fu C; Qi K; Zhang X; Li Z; Xu K; Qiao J; Zeng L
Int J Radiat Biol; 2021; 97(2):240-248. PubMed ID: 33253621
[TBL] [Abstract][Full Text] [Related]
14. [Idiopathic thrombocytopenic purpura in children].
Gebauer E; Vijatov G
Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
[TBL] [Abstract][Full Text] [Related]
15. The spleen dictates platelet destruction, anti-platelet antibody production, and lymphocyte distribution patterns in a murine model of immune thrombocytopenia.
Aslam R; Kapur R; Segel GB; Guo L; Zufferey A; Ni H; Semple JW
Exp Hematol; 2016 Oct; 44(10):924-930.e1. PubMed ID: 27417974
[TBL] [Abstract][Full Text] [Related]
16. Autologous
Mahevas M; Van Eeckhoudt S; Moulis G; Limal N; Languille L; Bierling P; Dossier A; Duriez F; Galicier L; Morin AS; Tamburini J; Chaoui D; Bouscary D; Jijakli AAL; Khellaf M; Vaida I; Michel M; Vercellino L; Jaddi H; Yollant A; Dosquet C; Godeau B; Chomienne C
Br J Haematol; 2019 Aug; 186(3):e44-e47. PubMed ID: 30950041
[No Abstract] [Full Text] [Related]
17. Investigation of antibody-coated liposomes as a new treatment for immune thrombocytopenia.
Deng R; Balthasar JP
Int J Pharm; 2005 Nov; 304(1-2):51-62. PubMed ID: 16171959
[TBL] [Abstract][Full Text] [Related]
18. The pathogenesis of chronic immune (idiopathic) thrombocytopenic purpura.
McMillan R
Semin Hematol; 2000 Jan; 37(1 Suppl 1):5-9. PubMed ID: 10676917
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology of platelet destruction in immune (idiopathic) thrombocytopenic purpura.
McFarland J
Blood Rev; 2002 Mar; 16(1):1-2. PubMed ID: 11913982
[TBL] [Abstract][Full Text] [Related]
20. The interpretation of platelet kinetic studies for the identification of sites of abnormal platelet destruction.
Peters AM; Saverymuttu SH; Wonke B; Lewis SM; Lavender JP
Br J Haematol; 1984 Aug; 57(4):637-49. PubMed ID: 6430336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
